Skip to main content
Equibles

Woodline Partners LP

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,004,214
-$95,953 QoQ
Shares Held
369,052
0.0% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 161 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. PHAT ranks #145 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in PHAT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,004,214 369,052
2026-03-31 $4,100,167 369,052
2025-12-31 $3,107,157 187,291
2025-09-30 $2,204,415 187,291
2025-06-30 $1,796,120 187,291
2025-03-31 $4,713,108 751,692
2024-12-31 $8,133,739 1,001,692
2024-09-30 $46,527,288 2,573,412
2024-06-30 $8,095,697 785,990
2024-03-31 $6,015,582 566,439
2023-12-31 $10,007,584 1,096,121
2023-09-30 $7,674,017 740,021
2023-06-30 $9,647,212 673,688
2021-09-30 $959,886 29,903
2021-03-31 $1,565,425 41,678